Equity Method Investments (Tables)

12 Months Ended

Dec. 31, 2024

Equity Method Investments [Abstract]

Schedule of Equity Method Investment

In the years ended December 31, 2024 and 2023, activity recorded for the Company’s equity method investment in Lab Services MSO is summarized in the following table:

Equity investment carrying amount at January 1, 2023	$	-
Payment for equity method investment:
The Company’s interest in the fair value of Lab Services MSO’s net assets at February 9, 2023		1,206,406
The Company’s interest in the net excess of Lab Services MSO’s fair value over net assets which was attributable to identifiable intangible assets at February 9, 2023		10,004,000
The Company’s interest in the net excess of Lab Services MSO’s fair value over net assets which was attributable to goodwill at February 9, 2023		9,456,261
Total payment for equity method investment		20,666,667
Lab Services MSO’s net income attributable to the Company		1,236,391
Intangible assets amortization amount		(611,356	)
Impairment of goodwill		(9,196,682	)
Equity investment carrying amount at December 31, 2023		12,095,020
Lab Services MSO’s net income attributable to the Company		79,923
Intangible assets amortization amount		(666,932	)
Distribution of earnings from equity investment		(611,888	)
Impairment of goodwill		(259,579	)
Equity investment carrying amount at December 31, 2024	$	10,636,544

Schedule of Summarized Financial Information, as Provided to the Company by the Investee

The tables below present the summarized financial information, as provided to the Company by the investee, for the unconsolidated company:

	December 31, 2024		December 31, 2023
Current assets	$	2,917,880	$	4,930,254
Noncurrent assets		4,509,185		5,228,044
Current liabilities		611,391		828,713
Noncurrent liabilities		4,346,725		4,104,183
Equity		2,468,949		5,225,402

Schedule of Financial Information

	For the year Ended December 31, 2024			For the Period from February 9, 2023 (Date of Investment) through December 31, 2023
Net revenue	$	13,558,711		$	12,699,683
Gross profit		3,534,503			4,744,277
(Loss) income from operation		(265,754	)		2,393,830
Net loss income		199,808			3,090,977